COLRAS: In-vivo Wear Behaviour of AS Coated Versus Uncoated Columbus® Total Knee Prosthesis

Sponsor
Aesculap AG (Industry)
Overall Status
Not yet recruiting
CT.gov ID
NCT05509972
Collaborator
Raylytic GmbH (Other)
250
3
136
83.3
0.6

Study Details

Study Description

Brief Summary

This clinical study is a Post-Market Clinical Follow-Up (PMCF) measure and is aiming to compare the in-vivo wear behaviour of the Columbus® total knee prosthesis between the standard Cobalt Chromium (CoCr) and the multilayer coated so called "Advanced Surface" (AS) of the same implant. The clinical investigation is designed as a International, prospective, longterm non-interventional study in order to gain clinical data of many patients within the routine clinical application of the investigational device.

Study Design

Study Type:
Observational
Anticipated Enrollment :
250 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
International, Prospective, Longterm Study Comparing the Clinical Outcome and In-vivo Wear Behaviour of AS Coated Versus Uncoated Columbus® Total Knee Prosthesis
Anticipated Study Start Date :
Nov 1, 2022
Anticipated Primary Completion Date :
Nov 1, 2023
Anticipated Study Completion Date :
Mar 1, 2034

Arms and Interventions

Arm Intervention/Treatment
Columbus® DD Primary CoCr

Columbus® Deep Dish (DD) Primary Cobalt Chromium (CoCr)

Device: total knee prosthesis implantation
Total Knee Arthroplasty (TKA) represents a well-established, reliable and successful treatment option for end-stage bicompartmental osteoarthritis or comparable conditions even in young patients compromised by knee pain and limitations of daily living
Other Names:
  • Columbus® Total Knee Arthroplasty
  • Columbus® DD Primary CoCr AS coated

    Columbus® Deep Dish (DD) Primary Cobalt Chromium (CoCr) Advanced Surface

    Device: total knee prosthesis implantation
    Total Knee Arthroplasty (TKA) represents a well-established, reliable and successful treatment option for end-stage bicompartmental osteoarthritis or comparable conditions even in young patients compromised by knee pain and limitations of daily living
    Other Names:
  • Columbus® Total Knee Arthroplasty
  • Outcome Measures

    Primary Outcome Measures

    1. Polyethylene wear over time [until 10 years postoperatively]

      The in-vivo wear of the Polyethylene (PE) tibial tray will be assessed using the observer independent method of the imaging core lab. The PE wear assessment is based on the absolute object position of the knee prosthesis over time.

    Secondary Outcome Measures

    1. Implant survival [until 10 years postoperatively]

      Kaplan-Meier Analysis is a standard statistical method to describe the survival of human subjects or medical products over a defined time period.

    2. Quality of Life [EQ-5D-5L] compared to baseline [preoperatively and 3 months, 12 months, 2 years, 5 years, 10 years postoperatively]

      The 5-dimension 5-level measure of the health status, developed by the EuroQol Group (EQ-5D-5L) is a simple and generic measure for clinical and economic assessment. Instructions for the user are directly included into the questionnaire and it consists of two pages. One cover five different dimensions (mobility, self care, usual activities, pain/discomfort, anxiety/depression) and the other one the EQ visual Analogue Scale (EQ-VAS). The VAS scale records the self rated health status of the patient from the level "the worst health you can imagine" to "the best health you can imagine". The answer of each of the five dimensions result in a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state.

    3. Progress of Clinical Outcome (Forgotten Joint Score-12) over follow-up period [3 months, 12 months, 2 years, 5 years, 10 years postoperatively]

      The Forgotten Joint Score-12 (FJS-12) Knee was designed to assess patient outcome in patients undergoing conservative or operative treatment of the knee. These Patient Reported Outcome (PRO) questionnaires focus on patients' awareness of a specific joint in everyday life. In 12 Items the awareness for the artificial joint is assessed by the patient, each on a five point scale (Never / Almost Never / Seldom / Sometimes / Mostly) The Forgotten Joint Score assessment consists of 12 questions and is scored on a 0-100 scale. The higher the score, the less the patient is aware of their affected joint when performing daily activities

    4. Progress of Clinical Outcome [Oxford Knee Score] compared to baseline [preoperatively and 3 months, 12 months, 2 years, 5 years, 10 years postoperatively]

      The Oxford Knee Score (OKS) is a reliable 12-item, patient-reported questionnaire originally developed and validated specifically to assess function and pain in patients undergoing total knee replacement. It is short, reproducible, valid and sensitive to clinically important changes over time. Each of the 12 questions on the OKS is scored in the same way with the score decreasing as the reported symptoms increase (i.e. become worse). All questions are laid out with response categories denoting least (or no) symptoms to the left of the page (scoring 4) and those representing greatest severity lying on the right hand side (scoring 0), as detailed for question 1 below. This method, when summed, produces overall scores running from 0 to 48 with 48 being the best outcome,

    5. Radiographic comparison of alignment over time [baseline (assessed at discharge from hospital up to 10 days postoperatively); 3 months; 12 months; 5 years; 10 years]

      Radiographs shall be standardized between centres as far as possible. Unless limited by patient or equipment constraints, all follow-up imaging examinations will be obtained according to the radiographic protocol of the hospital and the set routine. The radiographic evaluation of Alignment combines Hip-Knee-Angle, femoral and tibial component alignment

    6. Radiographic comparison of implant migration over time [baseline (assessed at discharge from hospital up to 10 days postoperatively); 3 months; 12 months; 5 years; 10 years]

      Radiographs shall be standardized between centres as far as possible. Unless limited by patient or equipment constraints, all follow-up imaging examinations will be obtained according to the radiographic protocol of the hospital and the set routine. The radiographic evaluation of implant migration comprises tibial and femoral components in m/l and a/p direction,

    7. Radiographic comparison of tibial slope over time [baseline (assessed at discharge from hospital up to 10 days postoperatively); 3 months; 12 months; 5 years; 10 years]

      Radiographs shall be standardized between centres as far as possible. Unless limited by patient or equipment constraints, all follow-up imaging examinations will be obtained according to the radiographic protocol of the hospital and the set routine. Any changes of Tibial slope over the follow-up period is documented in the radiographic evaluation

    8. Radiographic comparison of the joint line over time [baseline (assessed at discharge from hospital up to 10 days postoperatively); 3 months; 12 months; 5 years; 10 years]

      Radiographs shall be standardized between centres as far as possible. Unless limited by patient or equipment constraints, all follow-up imaging examinations will be obtained according to the radiographic protocol of the hospital and the set routine. Any changes of the joint line over the follow-up period is documented in the radiographic evaluation

    9. Adverse events / serious adverse events [During the course of the study up to 10 years postoperatively]

      During the course of the study, any upcoming intra- or postoperative (serious) adverse events (AE / SAE) or device effects related or not related to the product under investigation or the procedure, will be documented in the dedicated Case Report Forms. The total number of AEs will be summarized and further evaluated by the sponsor and reported according to local legislation and necessity. Recorded complications will be categorized and analyzed in order to assess the safety of the investigational product

    10. Number of Participants with radiological complications over time [During the course of the study up to 10 years postoperatively]

      Radiographs shall be standardized between centres as far as possible. Unless limited by patient or equipment constraints, all follow-up imaging examinations will be obtained according to the radiographic protocol of the hospital and the set routine. All radiologically evident complications (including fracture, wear, loosening or radiolucencies) are cumulatively documented over the period of follow-up.

    11. Biomechanical analysis of retrievals in case of revision [During the course of the study up to 10 years postoperatively]

      Available retrievals of explanted investigational products will be analysed by the biomechanical laboratory of the sponsor according to an analysis protocol which includes the oxidation profile, the wear behaviour, the mechanics and the cumulative linear abrasion of these retrievals.

    Other Outcome Measures

    1. Baseline data [preoperatively]

      Demographics and medical history

    2. Implant specifications [intraoperatively]

      The size and material of each component (tibial and femoral implant, liners, patella resurfacing) of the used implant are documented.

    3. Surgery time [intraoperatively]

      the Surgery time from first cut to wound closure is documented

    4. Axis Alignment data according to OrthoPilot® record [intraoperatively]

      The orthopaedic navigation system AESCULAP® OrthoPilot® Elite is based on 25 years of experience. During the navigated surgery a record with data on intraoperatively achieved alignment / joint line restoration is stored.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    45 Years to 75 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Indication for a primary bicondylar total knee endoprosthesis with the Columbus® DD knee prosthesis

    • Written signed informed consent of patient

    • Willingness and mental ability to participate at the long-term follow-up examinations

    Exclusion Criteria:
    • Pregnancy

    • Patient age <45 and >75years

    • Acute inflammatory arthritis

    • Coagulation disorders (e.g. Haemophilia)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Lakeview Private Hospital Orthopaedics Bella Vista New South Wales Australia 2153
    2 Norwest Private Hospital Bella Vista New South Wales Australia 2153
    3 Universitätsklinik Freiburg Freiburg Baden-Württemberg Germany 79106

    Sponsors and Collaborators

    • Aesculap AG
    • Raylytic GmbH

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Aesculap AG
    ClinicalTrials.gov Identifier:
    NCT05509972
    Other Study ID Numbers:
    • AAG-O-H-2024
    First Posted:
    Aug 22, 2022
    Last Update Posted:
    Aug 22, 2022
    Last Verified:
    Aug 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Aesculap AG
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 22, 2022